Sarah Wise, MD
Otolaryngic Allergy · Atlanta, GANPI 1053348060
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $63,891 of the $77,014 with a category attached, or 83.0%. 13 manufacturers reported payments, led by Sanofi at 26.0% of the total. 2025 is the largest year on record at $36,698, 2.9 times the $12,686 reported in 2019.
Across 89 payments — averaging $865.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$20K
- Optinose US, Inc.$19K
- Regeneron Healthcare Solutions, Inc.$14K
- GSK$8K
- Medtronic$5K
- Genentech, Inc.$3K
- plus $9K from 7 others
Across 1 payment — averaging $500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi$500
What the payments were for
- Consulting fees$63,89183%
- Speaking & faculty fees$8,39111%
- Travel & lodging$1,2422%
- Food & beverage$3,4905%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 11 | $19,992 |
| Optinose US, Inc. | 23 | $19,300 |
| Regeneron Healthcare Solutions, Inc. | 12 | $13,996 |
| GSK | 7 | $7,557 |
| Medtronic(2 entities) | 17 | $4,535 |
| Genentech, Inc. | 1 | $2,680 |
| Eli Lilly | 1 | $2,400 |
| Chitogel Limited | 3 | $2,250 |
| AstraZeneca | 4 | $2,182 |
| Alk-abello, Inc | 5 | $1,417 |
| Neurent Medical Limited | 1 | $500 |
| Aerin Medical Inc. | 3 | $177 |
| Stryker | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$19,598
- Xhance$19,160
- NUCALA$3,200
- XOLAIR$2,680
- Chitogel Endoscopic Sinus Surgery Kit$2,250
- TEZSPIRE$1,611
- Odactra$1,250
- Ragwitek$1,250
- Grastek$1,250
- NEUROMARK Device$500
- NEUROMARK Radiofrequency Generator$500
- STEALTHSTATION S8 PLATFORM$290
- NUVENT$250
- PROPEL$187
- FUSION$115
How this compares
Too few otolaryngic allergy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 14 | $54,842 |
| Azelastine Hcl | 16 | $618 |
| Ipratropium Bromide | 17 | $464 |
| Doxycycline Hyclate | 13 | $191 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Atlanta
- John DelgaudioAtlanta$49K
- Daniel SpielmanAtlanta$4K
- Kody BolkAtlanta$2K
- Emily BarrowAtlanta$1K
- Anthony BotrosAtlanta$820
- David DillardAthens$9K
- Michael SylvesterFayetteville$5K
- David OliverSavannah$5K
- Thomas EdwardsDecatur$4K
- Michael CallahanGainesville$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.